SOURCE: Kadmon Corporation

Kadmon Corporation

July 06, 2015 09:30 ET

Kadmon Corporation to Present at the Cantor Fitzgerald Inaugural Healthcare Conference

NEW YORK, NY--(Marketwired - Jul 6, 2015) - Kadmon Corporation, LLC, today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer of Kadmon, will present at the Cantor Fitzgerald Inaugural Healthcare Conference on Wednesday, July 8, 2015 at 4:45 p.m. ET in New York City. Dr. Waksal will provide an overview of Kadmon and its clinical and commercial programs. 

In addition, Samuel D. Waksal, Ph.D., Founder and Chief of Innovation, Science and Strategy at Kadmon, will participate in a panel discussion at the conference, titled "Continued Opportunities in Immuno-Oncology: Exploring Next-Generation Checkpoint Inhibition," to take place at 11:15 a.m. ET.

About Kadmon Corporation
Kadmon Corporation, LLC, is a vertically integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs. We have a diversified product pipeline in autoimmune and fibrotic diseases, oncology, monogenic diseases and metabolic disease. For more information, visit

This press release contains forward-looking statements. These forward-looking statements are based on management's expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. The information contained in this press release is believed to be current as of the date of original issue. Kadmon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

Contact Information

  • Contact Information
    Ellen Tremaine
    Investor Relations
    Email Contact